-
1 Comment
Vcanbio Cell & Gene Engineering Corp., Ltd is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.
From a valuation standpoint, the stock is 31.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.6.
Vcanbio Cell & Gene Engineering Corp., Ltd's total revenue rose by 3.8% to $350M since the same quarter in the previous year.
Its net income has increased by 70.5% to $52M since the same quarter in the previous year.
Finally, its free cash flow fell by 17.0% to $45M since the same quarter in the previous year.
Based on the above factors, Vcanbio Cell & Gene Engineering Corp., Ltd gets an overall score of 4/5.
| ISIN | CNE000000545 |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | SHG |
| Beta | None |
|---|---|
| Market Cap | 10B |
| PE Ratio | 93.25 |
| Target Price | None |
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell detection tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600645.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
